Drug treatment practitioners’ perceptions of methadone diversion and their responses to it

References

• Adams AS, Soumerei SB, Lomas J, Ross-Degnan D. Evidence of self-report bias in assessing adherence to guidelines. International Journal of Quality in Health Care 1999; 11: 187–192
   PubMed Web of Science ®Google Scholar
• Bell J. The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective. Addiction 2010; 105: 1531–1537
   PubMed Web of Science ®Google Scholar
• Best D, Harris J, Gossop M, Farrell M, Finch E, Noble A, Strang J. Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and Alcohol Review 2000; 19: 9–16
   Web of Science ®Google Scholar
• Caplehorn JRM, Bell J. Methadone dosage and retention of patients in maintenance treatment. The Medical Journal of Australia 1991; 15: 195–199
   Google Scholar
• Corkery J, Schifano F, Ghodse H, Oyefeso A. The effects of methadone and its role in fatalities. Human Psychopharmacology: Clinical and Experimental 2004; 19: 565–576
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug and Alcohol Dependence 1996; 43: 191–198
   PubMed Web of Science ®Google Scholar
• Dasgupta N, Bailey EJ, Cicero T, Inciardi J, Parrino M, Rodenblum A, Dart RC. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Medicine 2010; 11: 1078–1091
   PubMed Web of Science ®Google Scholar
• Davis W, Johnson B. Prescription opioid use, misuse, and diversion among street drug users in New York city. Drug and Alcohol Dependence 2008; 92: 267–276
   PubMed Web of Science ®Google Scholar
• Department of Health (England) and the devolved administrations (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive.
   Google Scholar
• Duffy P, Baldwin H. The nature of methadone diversion in England: A Merseyside case study. Harm Reduction Journal 2012; 9(3)1–10
   PubMed Web of Science ®Google Scholar
• Eccles MP, Hrisos S, Francis J, Kaner E, Dickinson HO, Beyer F, Johnston M. Do self-reported intentions predict clinicians’ behaviour: A systematic review. Implementation Science 2006; 1: 28
   PubMed Web of Science ®Google Scholar
• Edmunds M, Hough M, Urquía N. Tackling local drug markets. Home Office, London 1996
   Google Scholar
• Farre M, Mas A, Torrens M, Moreno V, Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug and Alcohol Dependence 2002; 65: 283–290
   PubMed Web of Science ®Google Scholar
• Fountain J, Griffiths P, Farrell M, Gossop M, Strang J. Diversion tactics: How a sample of drug misusers in treatment obtained surplus drugs to sell on the illicit market. International Journal of Drug Policy 1997; 9: 159–167
   Google Scholar
• Fountain J, Griffiths P, Farrell M, Gossop M, Strang J. Benzodiazepines in polydrug-using repertoires: The impact of the decreased availability of temazepam gel-filled capsules. Drugs: Education, Prevention and Policy 1999; 6: 61–69
   Web of Science ®Google Scholar
• Fountain J, Strang J, Gossop M, Farrel M, Griffiths P. Diversion of prescribed drugs by drug users in treatment: Analysis of the UK market and new data from London. Addiction 2000; 95: 393–406
   PubMed Web of Science ®Google Scholar
• Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, , Somaini L, et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011; 35: 483–489
   PubMed Web of Science ®Google Scholar
• Glaser BG, Strauss AL. The discovery of grounded theory. Aldine, Chicago, IL 1967
   Google Scholar
• Golstein A, Hansteen RW, Horns WH. Control of methadone dosage by patients. Journal of the American Medical Association 1975; 234: 724–737
   Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Routes of drug administration and multiple drug misuse: Regional variations among clients seeking treatment at programmes throughout England. Addiction 2000; 95: 1197–1206
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Browne N, Marsden J. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. Journal of Substance Abuse Treatment 2003; 24: 313–321
   PubMed Web of Science ®Google Scholar
• Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. The American Journal of Drug and Alcohol Abuse 2008; 34: 347–353
   PubMed Web of Science ®Google Scholar
• Hall W, Degenhardt L. Regulating opioid prescribing to provide access to effective treatment while minimizing diversion: An overdue topic for research. Addiction 2007; 102: 1685–1688
   PubMed Web of Science ®Google Scholar
• Hay G, Gannon M, MacDougall J, Millar T, Eastwood C, McKeganey N. Estimates of the prevalence of opiate use and/or crack cocaine use (2006/07). Home Office, London 2008
   Google Scholar
• Heinemann A, Iwersen-Bergmann S, Stein S, Schmoldt A, Püschel K. Methadone-related fatalities in Hamburg 1990–1999: Implications for quality standards in maintenance treatment?. Forensic Science International 2000; 113: 449–455
   PubMed Web of Science ®Google Scholar
• Hoare J, Moon D. Drug misuse declared: Findings from the 2009/10 British Crime Survey: England and Wales. Home Office, London 2010
   Google Scholar
• Home Office. Drug strategy 2010: Reducing demand, restricting supply, building recovery: Supporting people to live a drug free life. Home Office, London 2010
   Google Scholar
• Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine 2007; 8: 171–183
   PubMed Web of Science ®Google Scholar
• Johnson M, (2004). The black market in methadone – Some reflections. Retrieved from http://www.smmgp.org.uk/download/others/other041.pdf
   Google Scholar
• Katz NP, Adams EH, Benneyan JC, Birnbaum HG, Budman SH, Buzzeo RW, , Lande SD, et al. Foundations of opioid risk management. The Clinical Journal of Pain 2007; 23: 103–118
   PubMed Web of Science ®Google Scholar
• King VL, Stoller KB, Hayes M, Umbricht A, Currens M, Kidorf MS, , Brooner RK, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence 2002; 65: 137–148
   PubMed Web of Science ®Google Scholar
• Larance B, Degenhardt L, O’Brien S, Lintzeris N, Winstock A, Mattick RP, , Ali R, et al. Prescribers’ perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug and Alcohol Review 2011; 30: 613–620
   PubMed Web of Science ®Google Scholar
• Latowsky M. Methadone death, dosage and torsade de pointes: Risk-benefit policy implications. Journal of Psychoactive Drugs 2006; 38: 513–519
   PubMed Web of Science ®Google Scholar
• Lauzon P, Vincelette J, Bruneau J, Lamothe F, Lachance N, Brabant M, Soto J. Illicit use of methadone among IV drug users in Montreal. Journal of Substance Abuse Treatment 1994; 11: 457–461
   PubMed Web of Science ®Google Scholar
• Lin C, Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug and Alcohol Dependence 2011; 117: 45–49
   PubMed Web of Science ®Google Scholar
• Madden ME, & Shapiro, S.L. (2011). The methadone epidemic: Methadone-related deaths on the rise in Vermont. The American Journal of Forensic Medicine and Pathology, 32, 131–135
   Google Scholar
• Matheson C, Bond C, Hickey F. Prescribing and dispensing for drug misusers in primary care: Current practice in Scotland. Family Practice 1999; 16: 375–379
   PubMed Web of Science ®Google Scholar
• Mitchell SG, Kelly SM, Brown BS, Schacht Reisinger H, Peterson JA, Ruhfa A, , Schwartz RP, et al. Uses of diverted methadone and buprenorphine by opioid addicted individuals in Baltimore, Maryland. The American Journal on Addictions 2009; 18: 346–355
   PubMed Web of Science ®Google Scholar
• Mohamad N, Bakar NHA, Musa N, Talib N, Ismail R. Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy. Harm Reduction Journal 2010; 7: 30
   PubMed Web of Science ®Google Scholar
• Morrison A, Elliott L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction 1997; 92: 1349–1352
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (2007). Methadone and buprenorphine for the management of opioid dependence. Retrieved from http://www.nice.org.uk/TA114
   Google Scholar
• Neale J. Drug users’ views of substitute prescribing conditions. International Journal of Drug Policy 1999; 10: 247–258
   Google Scholar
• Neale J. Methadone, methadone treatment and non-fatal overdose. Drug and Alcohol Dependence 2000; 58: 117–124
   PubMed Web of Science ®Google Scholar
• Office for National Statistics (2010). Mid year population estimates 2009: 24/06/10. Retrieved from http://www.statistics.gov.uk/statbase/Product.asp?vlnk=15106
   Google Scholar
• Parker H, Kirby P. Methadone maintenance and crime reduction on Merseyside. Home Office Police Research Group, London 1996
   Google Scholar
• Parker H, Newcombe R. Heroin use and acquisitive crime in an English community. The British Journal of Sociology 1987; 38: 331–350
   PubMed Web of Science ®Google Scholar
• Resnick RB, Butler P, Washton AM. Patient self-adjustment of methadone maintenance dose. Problems of drug dependence1981: Proceedings of the 43rd annual scientific meeting, the committee on problems of drug dependence, inc., LS Harris. National lnstitute on Drug Abuse, Maryland 1981; 327–330
   Google Scholar
• Risser D, Honigschnabl S, Stichenwirth M, Pfudl S, Sebald D, Kaff A, Bauer G. Mortality of opiate users in Vienna, Austria. Drug and Alcohol Dependence 2001; 64: 251–256
   PubMed Web of Science ®Google Scholar
• Ritter A, Di Natale R. The relationship between take-away methadone policies and methadone diversion. Drug and Alcohol Review 2005; 24: 347–352
   PubMed Web of Science ®Google Scholar
• Robles E, Miller FB, Gilmore-Thomas KK, McMillan DE. Implementation of a clinic policy of client-regulated methadone dosing. Journal of Substance Abuse Treatment 2001; 20: 225–230
   PubMed Web of Science ®Google Scholar
• Roche A, McCabe S, Smyth BP. Illicit methadone use and abuse in young people accessing treatment for opiate dependence. European Addiction Research 2008; 14: 219–225
   PubMed Web of Science ®Google Scholar
• Seymour A, Black M, Jay J, Cooper G, Weir C, Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction 2003; 98: 995–1002
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J. Methadone prescribing to opiate addicts by private doctors: Comparison with NHS practice in south east England. Addiction 2001; 96: 567–576
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M. The prescribing of methadone and other opioids to addicts: National survey of GPs in England and Wales. British Journal of General Practice 2005; 55: 444–451
   PubMed Web of Science ®Google Scholar
• Sunjic S, Howard J. “Non injectables”: Methadone syrup and benzodiazepine injection by methadone-maintained clients. Drug and Alcohol Review 1996; 15: 245–250
   PubMed Web of Science ®Google Scholar
• The National Treatment Agency for Substance Misuse (2004). Methadone dose and methadone maintenance treatment. Retrieved from http://www.nta.nhs.uk
   Google Scholar
• The National Treatment Agency for Substance Misuse. NTA Business Plan 2010–2011. The National Treatment Agency for Substance Misuse, London 2010
   Google Scholar
• van Ameijden E, Langendam E, Coutinho R. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behaviors 1999; 24: 559–563
   PubMed Web of Science ®Google Scholar
• Vlahov D, O’Driscoll P, Mehta SH, Ompad DC, Gern R, Galai N, Kirk GD. Risk factors for methadone outside treatment programs: Implications for HIV treatment among injection drug users. Addiction 2007; 102: 771–777
   PubMed Web of Science ®Google Scholar
• Weinrich M, Stuart M. Provision of methadone treatment in primary care medical practices: Review of the Scottish experience and implications for US policy. Journal of the American Medical Association 2000; 283: 1343–1348
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lea T. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia. Substance Use and Misuse 2010; 45: 240–252
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lea T, Sheridan J. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy 2008; 19: 450–458
   PubMed Web of Science ®Google Scholar